CONCIZUTRACE
LIVE

Serial Number

79387857

Owner

Randox Laboratories Limited

Attorney

Daniel D. Frohling

Filing Date

Jun 22, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CONCIZUTRACE Trademark

Serial Number: 79387857 • Registration: 8054628

CONCIZUTRACE is a trademark filed by Randox Laboratories Limited on June 22, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Randox Laboratories Limited (18 trademarks)

Ardmore
Co. Antrim , GB

Entity Type: 99

Trademark Details

Filing Date

June 22, 2023

Registration Date

December 9, 2025

Published for Opposition

October 21, 2025

Goods & Services

Pharmaceutical, veterinary and sanitary preparations and substances for use in medical clinical analysis and testing in connection with diagnosing cardiovascular diseases, coronary heart disease, brain diseases, cancer, diabetes, kidney diseases, renal diseases, anemia, dementia, nervous system dysfunctions, diseases of the central nervous system, autoimmune diseases, allergy, vascular diseases, infertility, menopause, early or delayed puberty, reproductive or non-reproductive disorders, gastrointestinal disorders, digestive diseases and conditions, metabolic diseases, hypercalcemia, thyroid diseases, bone disorders, respiratory diseases, infectious diseases, sexually transmitted diseases, and urinary tract infections, testing high or low levels of testosterone, testing for calcium absorption, testing of blood levels, antimicrobial testing, and screening for drug use blood sera and blood anti-sera, for medical and veterinary use; diagnostic preparations and substances for medical and veterinary purposes; clinical diagnostic reagents for medical or veterinary use; clinical diagnostic reagents for medical and veterinary use in vitro and/or vivo use; diagnostic scanning agents for medical and veterinary use for in vivo use; diagnostic testing materials for medical use in the detection and monitoring of disease states in vitro, namely, chemical reagents for medical and veterinary use; clinical laboratory analytical instruments in the nature of clinical medical reagents; clinical medical reagents; reagents for use in diagnostic tests for medical and veterinary purposes; reagents for use with analyzers for medical and veterinary purposes; clinical medical diagnostic reagents; diagnostic scanning agents, for medical purposes; diagnostic kits comprised of diagnostic test reagents, diagnostic agents, preparations and substances, wash buffer, assay buffer, microtiter plate, acidification plate, and neutralization plate for use in medical clinical analysis and testing in connection with diagnosing cardiovascular diseases, coronary heart disease, brain diseases, cancer, diabetes, kidney diseases, renal diseases, anemia, dementia, nervous system dysfunctions, diseases of the central nervous system, autoimmune diseases, allergy, vascular diseases, infertility, menopause, early or delayed puberty, reproductive or non-reproductive disorders, gastrointestinal disorders, digestive diseases and conditions, metabolic diseases, hypercalcemia, thyroid diseases, bone disorders, respiratory diseases, infectious diseases, sexually transmitted diseases, and urinary tract infections, testing high or low levels of testosterone, testing for calcium absorption, testing of blood levels, antimicrobial testing, and screening for drug use for medical purposes

Medical apparatus and instruments for medical use, namely, for use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins and hormones; diagnostic apparatus and instruments for medical use use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; diagnostic imaging apparatus for medical use; clinical analyzers for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs for medical and veterinary use; diagnostic testing apparatus and instruments for use in immunoassay procedures, namely, for use in the measurement of antibodies, immunoglobulins, hormones and drugs representing various drug classes; detectors and diagnostic testing apparatus and instruments for use in immunoassay procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; parts and fittings for all the aforesaid goods, namely, x-ray diagnostic apparatus, ultrasound diagnostic apparatus, probes for use in in vitro diagnostic testing procedures, clinical chemistry analyzers, blood testing apparatus; clinical laboratory analytical instruments in the nature x-ray diagnostic apparatus, ultrasound diagnostic apparatus, probes for use in in vitro diagnostic testing procedures, clinical chemistry analyzers, blood testing apparatus, diagnostic saliva vials, all being clinical laboratory analytical instruments for medical or veterinary use

Medical services; hygienic and beauty care for human beings; consulting services relating to health care; health advice and information services; medical care services in the field of general health, immunology, nutrition, cardiac diseases, metabolism, cancer, diabetes, fertility, thyroid function; health clinic services; healthcare services; medical consultations and lifestyle consultations, namely, professional consultations to individuals to assess their personal health and health wellbeing; medical health assessment services; health screening services in the field of general health, immunology, nutrition, cardiac diseases, metabolism, cancer, diabetes, fertility, thyroid function; diagnostic health screening services in the field of general health, immunology, nutrition, cardiac diseases, metabolism, cancer, diabetes, fertility, thyroid function; providing medical information to patients in the form of preparation of reports in the field of general health, immunology, nutrition, cardiac diseases, metabolism, cancer, diabetes, fertility, thyroid function relating to health care matters; professional consultancy relating to health; medical testing; testing and analysis in the nature of medical diagnostic services; nursing services; nursing care services; medical health and fitness assessment services, for medical purposes; medical advisory and consultancy services relating to immunology; advisory and consultancy services relating to nutrition; cholesterol testing; genetic testing for medical purposes; hearing tests; services for the testing of blood, for medical purposes; services for the medical testing of blood sera; services for the medical testing of urine; services for medical testing of bone functions; services for medical testing of major body organs; services for the medical testing of fertility hormone levels; health screening in the field of health care for pregnant women; pregnancy testing services; prenatal medical care services; postnatal care services in the nature of deficiency diagnostics and personalized health plans; services for the medical testing of diabetes; services for the medical testing of thyroid function; services for medical testing of blood iron levels; medical assistance; medical clinics; information, consultancy and advice relating to any of the aforesaid services

Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; diagnostic preparations for scientific purposes; chemical reagents, other than for medical or veterinary purposes; enzymes and proteins for industrial use; diagnostic preparations for analysis of food products and water for scientific and research purposes; diagnostic testing materials in the nature diagnostic reagents for scientific use

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Jun 20, 2026 FICS
FINAL DISPOSITION PROCESSED
Jun 20, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 9, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 9, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 24, 2025 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 24, 2025 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 27, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 27, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 27, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 24, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 29, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 29, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 12, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 11, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 30, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 26, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 25, 2024 REPR